Pegilodecakin (LY3500518)

pegilodecakin · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegilodecakin (LY3500518), covering 2026-07-09 to 2026-07-09. Get the full timeline:

Most recent: Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]